Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
fda guidance on clinical trials | 0.31 | 0.8 | 7906 | 40 |
fda guidance on clinical trials during covid | 1.3 | 0.8 | 3987 | 57 |
fda guidance on clinical trial diversity | 0.98 | 0.3 | 7666 | 66 |
fda guidance on clinical trial endpoints | 0.89 | 0.1 | 6316 | 97 |
fda guidance on clinical trial recruitment | 1.91 | 0.1 | 6524 | 99 |
fda guidance on diversity in clinical trials | 0.35 | 0.2 | 7702 | 29 |
fda guidance on decentralized clinical trials | 0.34 | 1 | 7513 | 89 |
fda guidance on monitoring clinical trials | 0.8 | 0.4 | 2556 | 85 |
fda guidance on placebo for clinical trials | 1.94 | 0.5 | 1398 | 16 |
fda guidance on adaptive clinical trials | 1.57 | 0.2 | 1099 | 89 |
clinical trials guidance documents fda | 1.07 | 0.8 | 416 | 63 |
clinical trials for covid | 0.92 | 0.1 | 3104 | 35 |
covid 19 fda guidance | 0.56 | 0.8 | 8829 | 10 |
fda guidelines for covid | 0.11 | 0.5 | 2596 | 23 |
current fda covid guidelines | 0.75 | 0.1 | 5612 | 33 |